|
ZNF765 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.803600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.998800E-01 |
| Normal-vs-Stage2 |
6.462200E-01 |
| Normal-vs-Stage3 |
1.848460E-04 |
| Normal-vs-Stage4 |
2.257700E-03 |
| Stage1-vs-Stage2 |
5.609000E-01 |
| Stage1-vs-Stage3 |
4.01740000000039E-05 |
| Stage1-vs-Stage4 |
1.078490E-03 |
| Stage2-vs-Stage3 |
5.808100E-02 |
| Stage2-vs-Stage4 |
6.968200E-02 |
| Stage3-vs-Stage4 |
9.435400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.308180E-01 |
| Normal-vs-AfricanAmerican |
6.574100E-04 |
| Normal-vs-Asian |
2.382800E-01 |
| Caucasian-vs-AfricanAmerican |
1.239920E-02 |
| Caucasian-vs-Asian |
2.723400E-01 |
| AfricanAmerican-vs-Asian |
2.302200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.128400E-01 |
| Normal-vs-Female |
5.020100E-02 |
| Male-vs-Female |
6.762600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.584600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.522200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.263300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.042260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.103400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.958600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.216600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.220000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.162800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.679380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.057970E-01 |
| Normal-vs-Grade 2 |
9.578400E-01 |
| Normal-vs-Grade 3 |
1.244060E-02 |
| Normal-vs-Grade 4 |
5.62659999999715E-05 |
| Grade 1-vs-Grade 2 |
2.738200E-01 |
| Grade 1-vs-Grade 3 |
4.065500E-02 |
| Grade 1-vs-Grade 4 |
2.502400E-03 |
| Grade 2-vs-Grade 3 |
7.541000E-03 |
| Grade 2-vs-Grade 4 |
2.22409999999229E-05 |
| Grade 3-vs-Grade 4 |
2.034100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.064600E-01 |
| Normal-vs-ccB subtype |
2.856000E-01 |
| ccA subtype-vs-ccB subtype |
1.780220E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.434000E-01 |
| Normal-vs-N1 |
5.385900E-02 |
| N0-vs-N1 |
1.048360E-01 |
|
|
